| Name | Title | Contact Details |
|---|---|---|
Jeff Pinto |
CIO and Head of AI | Profile |
Preferred Commerce, Inc. (OCBM) is the supplier and provider of Elev8, products that contain some of the world`s most powerful antioxidants and cell reparation enzymes such as SOD (Superoxide Dismutase) mononucleotides and other key ingredients that promote healthier cell activity in all living things. SOD is an enzyme that alternately catalyzes the dismutation (or partitioning) of the superoxide (O2-) radical into either ordinary molecular oxygen (O2) or hydrogen peroxide (H2O2). Hydrogen peroxide is also damaging and is degraded by other enzymes such as catalase. Preferred Commerce`s specially formulated Elev8 products have been shown to provide relief to people who have Rheumatoid Arthritis, visible signs of skin damage, Scleroderma, Cataracts, Gout, inflammation, Interstitial Cystitis, Osteoarthritis, Parkinson`s Disease, Alzheimer`s disease, and ADHD, not to mention providing a stimulus for overall healthier lifestyles, cardiovascular health, and mental capacity and focus to people without any known health issues. Preferred Commerce has long been a solution provider to the horticulture and agriculture industries, as well as to consumers. In addition, the company has created training and educational products that have fueled billions of dollars in sales for Fortune 500 companies, while its family-friendly how-to-grow products have educated nearly 1 million children on how to successfully grow their own healthy food at home. As today`s health concerns are escalating, Preferred Commerce feels that Elev8 can play an important part in providing people with healthier lifestyles.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Alzheimer's Association is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Montrose Counseling Center is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
L&M Healthcare Communications is a Mountainside, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.